Jeff Kramer
Overview
Explore the profile of Jeff Kramer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
130
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Erturk M, Panken E, Conroy M, Edmonson J, Kramer J, Chatterton J, et al.
Front Hum Neurosci
. 2020 Mar;
14:34.
PMID: 32153375
Introduction: MRI gradient-fields may induce extrinsic voltage between electrodes and conductive neurostimulator enclosure of implanted deep brain stimulation (DBS) systems, and may cause unintended stimulation and/or malfunction. Electromagnetic (EM) simulations...
2.
Liem L, van Dongen E, Huygen F, Staats P, Kramer J
Reg Anesth Pain Med
. 2016 May;
41(4):511-9.
PMID: 27224659
Chronic neuropathic pain is a widespread problem with negative personal and societal consequences. Despite considerable clinical neuroscience research, the goal of developing effective, reliable, and durable treatments has remained elusive....
3.
Bagdanoff J, Donoviel M, Nouraldeen A, Carlsen M, Jessop T, Tarver J, et al.
J Med Chem
. 2010 Nov;
53(24):8650-62.
PMID: 21090716
Sphingosine 1-phosphate lyase (S1PL) has been characterized as a novel target for the treatment of autoimmune disorders using genetic and pharmacological methods. Medicinal chemistry efforts targeting S1PL by direct in...
4.
Bagdanoff J, Donoviel M, Nouraldeen A, Tarver J, Fu Q, Carlsen M, et al.
J Med Chem
. 2009 Jun;
52(13):3941-53.
PMID: 19489538
During nearly a decade of research dedicated to the study of sphingosine signaling pathways, we identified sphingosine-1-phosphate lyase (S1PL) as a drug target for the treatment of autoimmune disorders. S1PL...